These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8835498)

  • 1. The absence of human beta 2-microglobulin increases the occurrence of ankylosing enthesopathy in HLA-B27 transgenic mice.
    Chopin M; Plichtova R; Urbero B; Pla M
    Clin Rheumatol; 1996 Jan; 15 Suppl 1():28-31. PubMed ID: 8835498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of MHC class I heterodimer expression in mouse ankylosing enthesopathy.
    Weinreich SS; Hoebe-Hewryk B; van der Horst AR; Boog CJ; Ivanyi P
    Immunogenetics; 1997; 46(1):35-40. PubMed ID: 9148786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous inflammatory arthritis in HLA-B27 transgenic mice lacking beta 2-microglobulin: a model of human spondyloarthropathies.
    Khare SD; Luthra HS; David CS
    J Exp Med; 1995 Oct; 182(4):1153-8. PubMed ID: 7561688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-B27 as a relative risk factor in ankylosing enthesopathy in transgenic mice.
    Weinreich S; Eulderink F; Capkova J; Pla M; Gaede K; Heesemann J; van Alphen L; Zurcher C; Hoebe-Hewryk B; Kievits F
    Hum Immunol; 1995 Feb; 42(2):103-15. PubMed ID: 7744613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA class-I-transgenic mice as model system to study MHC-restricted antigen recognition in man.
    Weiss EH; Schliesser G; Botteron C; McMichael A; Riethmüller G; Kievits F; Ivanyi P; Brem G
    Scand J Rheumatol Suppl; 1990; 87():91-6. PubMed ID: 2259893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unraveling the mystery of HLA-B27 association with human spondyloarthropathies using transgenic and knock out mice.
    Khare SD; Luthra HS; David CS
    Semin Immunol; 1998 Feb; 10(1):15-23. PubMed ID: 9529652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-B27 heavy chains contribute to spontaneous inflammatory disease in B27/human beta2-microglobulin (beta2m) double transgenic mice with disrupted mouse beta2m.
    Khare SD; Hansen J; Luthra HS; David CS
    J Clin Invest; 1996 Dec; 98(12):2746-55. PubMed ID: 8981920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Animal models of HLA-B27-associated diseases: new outcomes.
    Hacquard-Bouder C; Ittah M; Breban M
    Joint Bone Spine; 2006 Mar; 73(2):132-8. PubMed ID: 16377230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-B27 transgenic mice are susceptible to collagen-induced arthritis: type II collagen as a potential target in human disease.
    Lee S; Khare SD; Griffiths MM; Luthra HS; David CS
    Hum Immunol; 2000 Feb; 61(2):140-7. PubMed ID: 10717806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide binding alpha1alpha2 domain of HLA-B27 contributes to the disease pathogenesis in transgenic mice.
    Khare SD; Lee S; Bull MJ; Hanson J; Luthra HS; Hammerling GJ; David CS
    Hum Immunol; 1999 Feb; 60(2):116-26. PubMed ID: 10027779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Animal models of HLA-B27-associated diseases.
    Breban M; Hacquard-Bouder C; Falgarone G
    Curr Mol Med; 2004 Feb; 4(1):31-40. PubMed ID: 15011957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-B27 heavy chain homodimers are expressed in HLA-B27 transgenic rodent models of spondyloarthritis and are ligands for paired Ig-like receptors.
    Kollnberger S; Bird LA; Roddis M; Hacquard-Bouder C; Kubagawa H; Bodmer HC; Breban M; McMichael AJ; Bowness P
    J Immunol; 2004 Aug; 173(3):1699-710. PubMed ID: 15265899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additional human beta2-microglobulin curbs HLA-B27 misfolding and promotes arthritis and spondylitis without colitis in male HLA-B27-transgenic rats.
    Tran TM; Dorris ML; Satumtira N; Richardson JA; Hammer RE; Shang J; Taurog JD
    Arthritis Rheum; 2006 Apr; 54(4):1317-27. PubMed ID: 16575857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arthritis in HLA-B27 transgenic animals.
    Taurog JD
    Am J Med Sci; 1998 Oct; 316(4):250-6. PubMed ID: 9766486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous inflammatory disease in HLA-B27 transgenic mice does not require transporter of antigenic peptides.
    Khare SD; Lee S; Bull MJ; Hanson J; Luthra HS; David CS
    Clin Immunol; 2001 Mar; 98(3):364-9. PubMed ID: 11237560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Similar cell surface expression of beta2-microglobulin-free heavy chains by HLA-B27 subtypes differentially associated with ankylosing spondylitis.
    Vázquez MN; López de Castro JA
    Arthritis Rheum; 2005 Oct; 52(10):3290-9. PubMed ID: 16200602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous inflammatory disease in HLA-B27 transgenic mice is independent of MHC class II molecules: a direct role for B27 heavy chains and not B27-derived peptides.
    Khare SD; Bull MJ; Hanson J; Luthra HS; David CS
    J Immunol; 1998 Jan; 160(1):101-6. PubMed ID: 9551961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New aspects in the pathogenesis of Bechterew disease].
    Märker-Hermann E; Sucké B; Meyer zum Büschenfelde KH
    Z Rheumatol; 1996; 55(1):4-18. PubMed ID: 8868146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strong association of HLA-B27 heavy chain with beta 2-microglobulin.
    Tran TM; Horejsí V; Weinreich S; Pla M; Breur BS; Capková J; Flieger M; Ivanyi P; Ivasková E
    Hum Immunol; 2000 Dec; 61(12):1197-201. PubMed ID: 11163075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-B27 in inbred and non-inbred transgenic mice. Cell surface expression and recognition as an alloantigen in the absence of human beta 2-microglobulin.
    Taurog JD; Lowen L; Forman J; Hammer RE
    J Immunol; 1988 Dec; 141(11):4020-3. PubMed ID: 3053904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.